Adaptive Biotechnologies
ADPT
ADPT
187 hedge funds and large institutions have $732M invested in Adaptive Biotechnologies in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 176 → 187 (+11)
3.84% less ownership
Funds ownership: 100.88% → 97.04% (-3.8%)
Holders
187
Holding in Top 10
2
Calls
$403K
Puts
$259K
Top Buyers
| 1 | +$11M | |
| 2 | +$4.27M | |
| 3 | +$4.16M | |
| 4 |
Goldman Sachs
New York
|
+$3.59M |
| 5 |
CC
Clearline Capital
New York
|
+$3.15M |
Top Sellers
| 1 | -$55.9M | |
| 2 | -$5.28M | |
| 3 | -$3.29M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.11M |
| 5 |
Jane Street
New York
|
-$2.65M |